Remove 2019 Remove Healthcare Remove Individual Remove Provider
article thumbnail

Patient experience with Social Prescribing Program in Ontario, Canada [Social determinants and vulnerable populations]

Annals of Family Medicine

Context Social Prescribing (SP) is an approach to help individuals address their health and social needs wherein a healthcare practitioner refers patients to non-clinal services in the community. Models of SP vary, and the experience of patients across these models is less known. ARC: All (N=17) participants used navigation.

Patients 130
article thumbnail

The Positive Impact of Direct Primary Care on Employer Healthcare Spending

Plum Health

In the ever-evolving landscape of healthcare, Direct Primary Care and Subscription-based Primary Care are emerging as promising models that could significantly benefit both employers and employees. These models simplify the healthcare business by removing insurance companies from basic primary care. As of 2019, 49.6%

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

An Evaluation of Gonorrhea and Chlamydia Incidence, Treatment, and Guideline Adherence in an Ambulatory Healthcare System [Infectious diseases (not respiratory tract)]

Annals of Family Medicine

Population Studied: Individuals with gonorrhea and chlamydia positive tests. Results: Between 1/1/2019 and 12/31/2021, 4385 persons were treated for chlamydia and gonorrhea were documented within the MedStar system. Setting: MedStar Health, a multidisciplinary and multispecialty health care system in the mid-Atlantic US.

article thumbnail

Episode 282: Anti-Racism in Medicine Series – Episode 20 – Medical Racism and Indigenous Peoples

The Clinical Problem Solvers

The dehumanization of individuals of color at the margins of society by the healthcare system is not simply a thing of the past, and is certainly a persistent phenomenon. Cindy Gladue, Brian Sinclair, and Joyce Echaquan are three Indigenous individuals who suffered immense harm at the hands of the healthcare system.

Medical 52
article thumbnail

Could the Road to an AKS Violation Be Paved with Good Intentions? Pfizer Asks SCOTUS

FDA Law Blog

In its petition filed earlier this month, Pfizer challenges HHS’s interpretation of the AKS as “staggeringly overbroad,” contrary to the congressional intent behind the AKS, and a threat to “almost any activity that facilitates patient access to federally funded healthcare.” Background.

article thumbnail

A Question 30 Years in the Making: Would a Final LDT Rule Withstand Judicial Scrutiny?

FDA Law Blog

The PR first sets out to establish that it has authority to regulate in vitro diagnostic “test systems” as devices, and not just the system’s individual components, such as reagents, instruments, specimen collection devices, and software. Specific features of the PR will foreseeably yield new bases for challenge.

article thumbnail

Let’s Listen to Patients: FDA Releases Final Guidance on Patient Engagement in the Design and Conduct of Medical Device Clinical Studies

FDA Law Blog

The Agency’s goal is demonstrated in its definition of patient engagement: “Patient engagement is defined as intentional, meaningful interactions with patients that provide opportunities for mutual learning, and effective collaborations.” .